NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









molmir Inc.

molmir Inc.

Private
KashiharaHealthcare & Life Scienceshttps://www.molmir.co.jp/

Last Round

Series A

Apr 22, 2026

Total Funding Raised

$1.88M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

molmir Inc. is a biotechnology company that has developed a unique technology to observe the dynamics of molecules to create new medicines for diseases such as ALS, Alzheimer's, cancer, and heart disease.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

drug discovery platformmolecular dynamicsundruggable targetsnuclear magnetic resonanceNMRdrug discovery servicesneurodegenerative diseaseprotein dynamicsCRO servicesanalytical chemistrypharmaceutical partnershipsprotein interaction analysisscreening assay developmentbiotechnologyJapanese biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

molmir Inc. Comparables

Compare molmir Inc. with similar companies based on industry and business-model similarity.

molmir Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nereid
79%
Medusa Therapeutics Limited
62%
Nuage Therapeutics
60%

molmir Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 22, 2026
SeedMay 24, 2024
Pre SeedNov 24, 2022

Key People

Founding team and executive leadership

Masataka Yamamoto

Board Director And COO, Founder And COO

Founding Team

Nozomi Tomimatsu

Chief Technology Officer

Executive Team

molmir Inc. Investors

Notable investors and investment history

molmir Inc. investors
InvestorRounds
BPキャピタル株式会社Series A
Ikeda Senshu CapitalSeries A, Seed
Mitsubishi UFJ CapitalSeries A, Seed
Nanto Capital PartnersSeries A
UntroD Capital Japan Inc.Series A, Pre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    $1.88M round with participation from Nanto Capital Partners.

  • May 24, 2024

    Seed round raised with participation from Ikeda Senshu Capital, Mitsubishi UFJ Capital, and UntroD Capital Japan Inc.

molmir Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

molmir Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about molmir Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKashihara
Employee Range2
Year Founded2022
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.